We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Sanquin

News List

Lonza and Sanquin partner for commercialisation of specialised MAT reagents for accurate and reliabl europeanpharmaceuticalreview
June 02, 2020
Lonza Sales AG, through its Bioscience Division has joined forces with Sanquin Reagents B.V. to enable drug developers and quality control laboratories to take full advantage of the power of the Monocyte Activation Test (MAT).
Lonza, Sanquin Partner for Commercialization of Specialized MAT Reagents americanpharmaceuticalreview
June 01, 2020
Lonza Sales AG, through its Bioscience Division, and Sanquin Reagents have entered into a strategic partnership.
Lonza, Sanquin Reagents Enter Strategic Pact contractpharma
May 29, 2020
Expands Lonza’s portfolio of endotoxin testing products and enables drug developers and QC labs to leverage sustainable MAT method.
Synthon and Sanquin to Develop Immuno-Oncology Therapeutic Leads Modulating the CD47-SIRPa Pathway americanpharmaceuticalreview
March 06, 2017
Synthon Biopharmaceuticals BV, an international biopharmaceutical company that is focused on developing new...